BrainCool AB (publ) comments on international clinical trial efforts with targeted temperature management (“TTM”)
Two major TTM clinical studies are underway in Germany and the US, the core markets of BrainCool. Both clinical studies are in-hospital studies only. · The ICECAP study in the US, which already has started with funding from NIH of MUSD 20. (See more detail about this trial in Appendix 1.) · The “Jena” study in Germany, which is not yet initiated. An ethical submission has been made with University of Jena as main site along with a total of 17 major cardiac arrest centres, as well as an application for funding from the German research council of MEUR 3. (See more detail about